Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-29
DOI
10.1038/s41467-019-14081-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-cell RNA-seq denoising using a deep count autoencoder
- (2019) Gökcen Eraslan et al. Nature Communications
- Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL
- (2019) Christian Schmidl et al. Nature Chemical Biology
- Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma
- (2019) Liang Zhang et al. Science Translational Medicine
- Dissection of Subclonal Evolution by Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated With Ibrutinib
- (2019) Ambrus Gángó et al. INTERNATIONAL JOURNAL OF CANCER
- Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
- (2018) David Ghez et al. BLOOD
- Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience
- (2018) Susan O’Brien et al. BLOOD
- Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer
- (2018) Tilly Varughese et al. CLINICAL INFECTIOUS DISEASES
- Systematic review of infectious events with the Bruton tyrosine kinase inhibitor ibrutinib in the treatment of hematologic malignancies
- (2018) Benjamin F. Tillman et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes
- (2018) Gabriela Galicia-Vázquez et al. Frontiers in Oncology
- Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
- (2018) Carol Moreno et al. LANCET ONCOLOGY
- Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
- (2018) Jennifer A. Woyach et al. NEW ENGLAND JOURNAL OF MEDICINE
- INTEGRATED ANALYSIS: OUTCOMES OF IBRUTINIB-TREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA (CLL/SLL) WITH HIGH-RISK PROGNOSTIC FACTORS
- (2017) T.J. Kipps et al. HEMATOLOGICAL ONCOLOGY
- Ibrutinib treatment improves T cell number and function in CLL patients
- (2017) Meixiao Long et al. JOURNAL OF CLINICAL INVESTIGATION
- Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway
- (2017) K Kondo et al. LEUKEMIA
- Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia
- (2017) Fie J. Vojdeman et al. LEUKEMIA & LYMPHOMA
- The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
- (2017) Dan A. Landau et al. Nature Communications
- Massively parallel digital transcriptional profiling of single cells
- (2017) Grace X. Y. Zheng et al. Nature Communications
- HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene loci
- (2016) Katherine M. Aird et al. JOURNAL OF CELL BIOLOGY
- DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia
- (2016) Christopher C Oakes et al. NATURE GENETICS
- Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
- (2016) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
- (2016) Maxim V. Kuleshov et al. NUCLEIC ACIDS RESEARCH
- RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence
- (2016) A. Galloway et al. SCIENCE
- Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks
- (2016) André F. Rendeiro et al. Nature Communications
- Single-Cell RNA-Sequencing Reveals a Continuous Spectrum of Differentiation in Hematopoietic Cells
- (2016) Iain C. Macaulay et al. Cell Reports
- Sambamba: fast processing of NGS alignment formats
- (2015) Artem Tarasov et al. BIOINFORMATICS
- LOLA: enrichment analysis for genomic region sets and regulatory elements in R and Bioconductor
- (2015) Nathan C. Sheffield et al. BIOINFORMATICS
- BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia
- (2015) S-S Chen et al. LEUKEMIA
- Non-coding recurrent mutations in chronic lymphocytic leukaemia
- (2015) Xose S. Puente et al. NATURE
- Spatial reconstruction of single-cell gene expression data
- (2015) Rahul Satija et al. NATURE BIOTECHNOLOGY
- Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK
- (2015) Idit Sagiv-Barfi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- Ibrutinib inhibits BCR and NF- B signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL
- (2014) S. E. M. Herman et al. BLOOD
- Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy
- (2014) J. A. Woyach et al. BLOOD
- Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads
- (2014) Hongshan Jiang et al. BMC BIOINFORMATICS
- Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study
- (2014) Jan A Burger et al. LANCET ONCOLOGY
- CODEX: a next-generation sequencing experiment database for the haematopoietic and embryonic stem cell communities
- (2014) Manuel Sánchez-Castillo et al. NUCLEIC ACIDS RESEARCH
- The UCSC Genome Browser database: 2015 update
- (2014) Kate R. Rosenbloom et al. NUCLEIC ACIDS RESEARCH
- Microenvironment dependency in Chronic Lymphocytic Leukemia: The basis for new targeted therapies
- (2014) Elisa ten Hacken et al. PHARMACOLOGY & THERAPEUTICS
- Hierarchical Bayesian modelling of gene expression time series across irregularly sampled replicates and clusters
- (2013) James Hensman et al. BMC BIOINFORMATICS
- The genomic landscape of chronic lymphocytic leukemia: clinical implications
- (2013) Víctor Quesada et al. BMC Medicine
- Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia
- (2013) P. G. Ferreira et al. GENOME RESEARCH
- Patterns of regulatory activity across diverse human cell types predict tissue identity, transcription factor binding, and long-range interactions
- (2013) N. C. Sheffield et al. GENOME RESEARCH
- Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial
- (2013) Susan O'Brien et al. LANCET ONCOLOGY
- Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position
- (2013) Jason D Buenrostro et al. NATURE METHODS
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolution of DNA Methylation Is Linked to Genetic Aberrations in Chronic Lymphocytic Leukemia
- (2013) C. C. Oakes et al. Cancer Discovery
- BLUEPRINT to decode the epigenetic signature written in blood
- (2012) David Adams et al. NATURE BIOTECHNOLOGY
- Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia
- (2012) Marta Kulis et al. NATURE GENETICS
- Fast gapped-read alignment with Bowtie 2
- (2012) Ben Langmead et al. NATURE METHODS
- The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
- (2011) S. Ponader et al. BLOOD
- B-cell receptor signaling in chronic lymphocytic leukemia
- (2011) F. K. Stevenson et al. BLOOD
- A Simple Approach to Ranking Differentially Expressed Gene Expression Time Courses through Gaussian Process Regression
- (2011) Alfredo A Kalaitzis et al. BMC BIOINFORMATICS
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
- (2011) Víctor Quesada et al. NATURE GENETICS
- Cistrome: an integrative platform for transcriptional regulation studies
- (2011) Tao Liu et al. GENOME BIOLOGY
- PU.1 is regulated by NF-κB through a novel binding site in a 17 kb upstream enhancer element
- (2009) N Bonadies et al. ONCOGENE
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- CXCR4 is required for the quiescence of primitive hematopoietic cells
- (2008) Yuchun Nie et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Model-based Analysis of ChIP-Seq (MACS)
- (2008) Yong Zhang et al. GENOME BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now